StockNews.AI
CBUS
StockNews.AI
92 days

Cibus to Participate in Alliance Global Partner's Annual Virtual Healthcare Company Showcase

1. Cibus will present at AGP Annual Healthcare Showcase on May 21, 2025. 2. Dr. Beetham will discuss gene-editing technology and commercialization strategies. 3. Cibus focuses on productivity traits addressing $300 billion global agricultural losses. 4. The company develops traits for major crops like canola, corn, and soybeans. 5. Cibus is a leader in high-throughput gene editing, reducing development time and costs.

4m saved
Insight
Article

FAQ

Why Bullish?

Cibus' advancements in gene editing may enhance productivity and attract more investment. Historical examples show innovation in biotech can lead to significant stock price increases, as seen with companies like BioTechne and Illumina.

How important is it?

The article outlines crucial advancements and strategies which may influence investor sentiments positively. Gene editing is a hot area in agri-tech, potentially yielding increased revenues for Cibus in the future.

Why Long Term?

The positive impact of ongoing gene-editing developments may take time to materialize. Historical patterns suggest that product commercialization and market adaptation take several quarters to affect stock prices significantly.

Related Companies

CRSPSGENTWST
May 19, 2025 16:05 ET  | Source: Cibus US LLC SAN DIEGO, May 19, 2025 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS) (the "Company"), a leading agricultural biotechnology company that uses proprietary gene editing technologies to develop plant traits (or specific genetic characteristics) in seeds, today announced that Peter Beetham, Co-Founder, President, and Interim Chief Executive Officer, will host a presentation at the AGP Annual Virtual Healthcare Company Showcase. During the presentation, Dr. Beetham will discuss the Company's progress in advancing its gene-editing technology platform, recent regulatory developments supporting agricultural innovation, and Cibus' commercialization strategy for its productivity trait pipeline. Presentation DetailsDate: Wednesday, May 21, 2025 Time: 4:40 p.m. ET (1:40 p.m. PT) Webcast link: https://us02web.zoom.us/webinar/register/WN_jB1HgKLvQFmUfC6VBT11mw About Cibus Cibus is a leader in gene edited productivity traits that address critical productivity and sustainability challenges for farmers such as diseases and pests which the United Nations estimates cost the global economy approximately $300 billion annually. Cibus is not a seed company. It is a technology company that uses gene editing to develop and license traits to seed companies in exchange for royalties on seed sales. Cibus' long-term focus is productivity traits for farmers for the major global row crops with large acreage such as canola, corn, rice, soybean, and wheat. Cibus is a technology leader in high-throughput gene editing technology that is expected to enable it to develop and commercialize plant traits at a fraction of the time and cost of conventional breeding. Cibus has developed a current pipeline of five productivity traits including important traits for weed management in Rice, Pod Shatter Reduction, and Sclerotinia (disease) resistance, which are its near-term focus. CIBUS CONTACTS: INVESTOR RELATIONSKaren Troeberktroeber@cibus.com858-450-2636 Jeff Sonnek – ICR jeff.sonnek@icrinc.comMEDIA RELATIONSColin Sanfordcolin@bioscribe.com203-918-4347

Related News